INS and type 2 diabetes mellitus: Yoo et al.,67 in this early prospective, randomized trial, investigated the potential effects of intermittent rtCGM use compared with BGM on glycemic control, weight, and self-management behaviors in a cohort of 65 T2D adults who were poorly controlled with basal insulin and/or oral hypoglycemic agent therapy (8.0% to 10% HbA1c range at baseline).67 Patients were randomly assigned to rtCGM or BGM use and followed for 3 months.